Pomdoctor Pivots Toward Predictive AI Healthcare Model

For decades, the global medical establishment has operated on an event-driven cycle: patients wait for symptoms, physicians provide a diagnosis, and treatment follows. Pomdoctor, listed on NASDAQ as POM, views this century-old framework as outdated. The company is now reconfiguring its existing infrastructure to prioritize continuous data collection, utilizing real-world datasets to identify potential health crises before they require emergency clinical intervention.

Chairman and CEO Zhenyang Shi emphasized that new technology allows for a transition from a "diagnose and treat" paradigm to one centered on "predict, alert, and intervene." The company plans to consolidate its physician network with AI-driven analysis and wearable device telemetry. This strategy is particularly targeted at chronic disease management, where constant monitoring can replace sporadic visits. Rather than building these capabilities as isolated features, Pomdoctor intends to weave them into a single, coordinated framework designed to provide personalized, proactive care for patients.